what are glp-1 drugs for weight loss List of approved and pending medications Decoding GLP-1 Weight Loss Medications
Description
Early human studies failed to show weight loss following a 24-week trial with GI181771X, a CCK1R agonist [22]
Coronary artery disease, alongside peripheral artery disease (PAD) and ischaemic strokes, is a manifestation of atherosclerosis, a process whereby arteries undergo gradual stiffening and stenosis due to the build-up of inflammatory, fibro-lipidic plaques in their subintimal compartment [3]
Questions remain concerning the drugs long-term effects on the body, in particular the GI tract
GLPs: current use and future considerations What does the second decade of GLP-1based therapies portend
GLP-1, substance P, and BNP, commonly show a vasodilation effect, while NPY has a significant hypertensive effect
